WO2001023417A3 - Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses - Google Patents

Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses Download PDF

Info

Publication number
WO2001023417A3
WO2001023417A3 PCT/EP2000/009500 EP0009500W WO0123417A3 WO 2001023417 A3 WO2001023417 A3 WO 2001023417A3 EP 0009500 W EP0009500 W EP 0009500W WO 0123417 A3 WO0123417 A3 WO 0123417A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
lak
human tumor
related polynucleotides
polynucleotides
Prior art date
Application number
PCT/EP2000/009500
Other languages
French (fr)
Other versions
WO2001023417A2 (en
Inventor
Y De Bassols Carlota Vinals
Original Assignee
Smithkline Beecham Biolog
Y De Bassols Carlota Vinals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9923154.0A external-priority patent/GB9923154D0/en
Priority claimed from GB0016839A external-priority patent/GB0016839D0/en
Application filed by Smithkline Beecham Biolog, Y De Bassols Carlota Vinals filed Critical Smithkline Beecham Biolog
Priority to EP00967820A priority Critical patent/EP1222198A2/en
Priority to AU77847/00A priority patent/AU7784700A/en
Priority to CA002386028A priority patent/CA2386028A1/en
Publication of WO2001023417A2 publication Critical patent/WO2001023417A2/en
Publication of WO2001023417A3 publication Critical patent/WO2001023417A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Abstract

CASB6411 polypeptides and polynucleotides and methods for producing such polpeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB6411 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
PCT/EP2000/009500 1999-09-30 2000-09-27 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses WO2001023417A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00967820A EP1222198A2 (en) 1999-09-30 2000-09-27 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses
AU77847/00A AU7784700A (en) 1999-09-30 2000-09-27 Novel compounds
CA002386028A CA2386028A1 (en) 1999-09-30 2000-09-27 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9923154.0A GB9923154D0 (en) 1999-09-30 1999-09-30 Novel compounds
GB9923154.0 1999-09-30
GB0016839.3 2000-07-07
GB0016839A GB0016839D0 (en) 2000-07-07 2000-07-07 Novel compounds

Publications (2)

Publication Number Publication Date
WO2001023417A2 WO2001023417A2 (en) 2001-04-05
WO2001023417A3 true WO2001023417A3 (en) 2001-05-17

Family

ID=26244627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/009500 WO2001023417A2 (en) 1999-09-30 2000-09-27 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses

Country Status (4)

Country Link
EP (1) EP1222198A2 (en)
AU (1) AU7784700A (en)
CA (1) CA2386028A1 (en)
WO (1) WO2001023417A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018768A2 (en) * 2001-08-24 2003-03-06 Incyte Genomics, Inc. Transmembrane protein differentially expressed in cancer
AU2007272272B2 (en) 2006-07-10 2012-04-12 Pba3 Biomed Gmbh Antimicrobial peptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035937A1 (en) * 1998-12-17 2000-06-22 Human Genome Sciences, Inc. 47 human secreted proteins
WO2000052161A2 (en) * 1999-03-01 2000-09-08 Incyte Pharmaceuticals, Inc. Leukocyte- and blood-associated proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035937A1 (en) * 1998-12-17 2000-06-22 Human Genome Sciences, Inc. 47 human secreted proteins
WO2000052161A2 (en) * 1999-03-01 2000-09-08 Incyte Pharmaceuticals, Inc. Leukocyte- and blood-associated proteins

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 1 January 1900 (1900-01-01), "QP46F08.X1 NCI CGAP C08 HOMO SAPIENS CDNA CLONE IMAGE:1926087 3', MRNA SEQUENCE", XP002162742, Database accession no. AI346622 *
DATABASE EMBL 1 January 1900 (1900-01-01), "TO74B03.XL NCI CGAP GAS4 HOMO SAPIENS CDNA CLONE IMAGE:2183981 3' SIMILAR TO TR:O43284 LAK-4P. ; MRNA SEQUENCE", XP002162740, Database accession no. AI799626 *
DATABASE EMBL 1 January 1900 (1900-01-01), "WC76H09.X1 NCI CGAP PAN1 HOMO SAPIENS CDNA CLONE IMAGE:2324609 3', MRNA SEQUENCE", XP002162744, Database accession no. AI697014 *
DATABASE EMBL 1 January 1900 (1900-01-01), "WO25D05.X1 NCI CGAP GAS4 HOMO SAPIENS CDNA CLONE IMAGE:2456361 3', MRNA SEQUENCE", XP002162741, Database accession no. AI921465 *
DATABASE EMBL 1 January 1900 (1900-01-01), ABE Y., TAKAOKA Y.: "HOMO SAPIENS MRNA FOR LAK-4P, COMPLETE CDS.", XP002162738, Database accession no. AB002405 *
DATABASE EMBL 1 January 1900 (1900-01-01), ABE Y., TAKAOKA Y.: "LAK-4P.", XP002162739, Database accession no. O43284 *
DATABASE EMBL 1 January 1900 (1900-01-01), HILLIER L., ET AL: "Z096Q02.RL STRATAGENE OVARIAN CANCER (#937219) HOMO SAPIENS CDNA CLONE IMAGE:594770 5', MRNA SEQUENCE", XP002162743, Database accession no. AA172244 *

Also Published As

Publication number Publication date
WO2001023417A2 (en) 2001-04-05
EP1222198A2 (en) 2002-07-17
AU7784700A (en) 2001-04-30
CA2386028A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
EP1466616A3 (en) Use of CASB616 polypeptides and polynucleotides for cancer treatment
WO2001062778A3 (en) Tumour-specific animal proteins
WO2000053748A3 (en) Casb618 polynucleotides and polypeptides and their use
WO2000058460A3 (en) Casb619 involved in colon cancers
WO2001023417A3 (en) Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses
WO2000043509A3 (en) Polynucleotides and their applications in diagnostics
WO2001034795A3 (en) Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
WO2001009339A3 (en) Moraxella catarrhalis antigen basb117
HK1047954A1 (en) Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
WO2002024729A3 (en) Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
WO2002066503A3 (en) H. influenzae antigen basb213
WO2001009335A3 (en) Moraxella catarrhalis antigen basb120
WO2001009337A3 (en) Moraxella catarrhalis antigens basb122 and basb124

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000967820

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2386028

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10089783

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000967820

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000967820

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP